Hester Biosciences Balance Sheet Health
Financial Health criteria checks 2/6
Hester Biosciences has a total shareholder equity of ₹2.9B and total debt of ₹2.7B, which brings its debt-to-equity ratio to 93.8%. Its total assets and total liabilities are ₹6.8B and ₹3.9B respectively. Hester Biosciences's EBIT is ₹372.6M making its interest coverage ratio 4.7. It has cash and short-term investments of ₹144.5M.
Key information
93.8%
Debt to equity ratio
₹2.73b
Debt
Interest coverage ratio | 4.7x |
Cash | ₹144.52m |
Equity | ₹2.92b |
Total liabilities | ₹3.91b |
Total assets | ₹6.83b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 524669's short term assets (₹2.4B) exceed its short term liabilities (₹1.3B).
Long Term Liabilities: 524669's short term assets (₹2.4B) do not cover its long term liabilities (₹2.6B).
Debt to Equity History and Analysis
Debt Level: 524669's net debt to equity ratio (88.8%) is considered high.
Reducing Debt: 524669's debt to equity ratio has increased from 48.9% to 93.8% over the past 5 years.
Debt Coverage: 524669's debt is not well covered by operating cash flow (8.3%).
Interest Coverage: 524669's interest payments on its debt are well covered by EBIT (4.7x coverage).